Russia registers nasal version of Sputnik V
Alexander Gintsburg, Director of the Gamaleya Center, had earlier told the agency that it will be efficient against the new Omicron coronavirus strain.
Alexander Gintsburg, Director of the Gamaleya Center, had earlier told the agency that it will be efficient against the new Omicron coronavirus strain.
The Sputnik V vaccine has demonstrated strong protection against Omicron variant, with over 2 times higher virus neutralising activity compared…
The meeting between Mansukh Mandaviya and Dr. Satish Reddy was held to discuss the Sputnik V vaccine production and its supply.
The officials also informed that the SII has already received cell and vector samples from the Gamaleya Center as part of the technology transfer process.
The Russian Direct Investment Fund (RDIF) and Serum Institute of India (SII), intend to produce over 300 million doses of the vaccine in India, per year.
The sources informed The Statesman that the chain of hospitals is expected to receive the doses of Sputnik V within two days at its headquarters based in Bengaluru, from where the doses will be passed on to different branches.
The children's hospital will be the second private vaccination centre in Delhi where the Sputnik V will be rolled out for the Covid-19 vaccination drive.
The hospital is giving Sputnik's shot only to its employees who haven't been immunized so far.
On May 14, Dr Reddy's announced a limited pilot soft launch of the Sputnik V vaccine in India, ahead of the commercial launch later in June.
It is to be noted that the vaccination process for the 18-44 age group has been temporarily suspended due to the unavailability of anti-Covid jabs. There has been no clarity since the last four days when the next supply of anti-Covid jabs will be supplied to Delhi.
